Correlation Between Enzymatica Publ and Millicom International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enzymatica Publ and Millicom International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzymatica Publ and Millicom International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzymatica publ AB and Millicom International Cellular, you can compare the effects of market volatilities on Enzymatica Publ and Millicom International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzymatica Publ with a short position of Millicom International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzymatica Publ and Millicom International.

Diversification Opportunities for Enzymatica Publ and Millicom International

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Enzymatica and Millicom is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Enzymatica publ AB and Millicom International Cellula in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Millicom International and Enzymatica Publ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzymatica publ AB are associated (or correlated) with Millicom International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Millicom International has no effect on the direction of Enzymatica Publ i.e., Enzymatica Publ and Millicom International go up and down completely randomly.

Pair Corralation between Enzymatica Publ and Millicom International

Assuming the 90 days trading horizon Enzymatica publ AB is expected to generate 1.74 times more return on investment than Millicom International. However, Enzymatica Publ is 1.74 times more volatile than Millicom International Cellular. It trades about 0.01 of its potential returns per unit of risk. Millicom International Cellular is currently generating about -0.03 per unit of risk. If you would invest  177.00  in Enzymatica publ AB on August 28, 2024 and sell it today you would earn a total of  0.00  from holding Enzymatica publ AB or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Enzymatica publ AB  vs.  Millicom International Cellula

 Performance 
       Timeline  
Enzymatica publ AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enzymatica publ AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Enzymatica Publ is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Millicom International 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Millicom International Cellular are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Millicom International may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Enzymatica Publ and Millicom International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enzymatica Publ and Millicom International

The main advantage of trading using opposite Enzymatica Publ and Millicom International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzymatica Publ position performs unexpectedly, Millicom International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Millicom International will offset losses from the drop in Millicom International's long position.
The idea behind Enzymatica publ AB and Millicom International Cellular pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal